Autologous blood transfusion (also known as autotransfusion) relies on cell saver technology to clean a patient’s blood and return it back to them, reducing and at times eliminating the need for transfusions of donated blood. Autotransfusion can be used in surgical procedures, whether planned or unplanned, as well as emergency situations where traumatic blood loss has occurred. Patients can receive their own blood back within minutes after it has been filtered through a cell salvage system.
The Jehovah’s Witness community has always maintained a ban against receiving transfusions of donated blood for religious reasons. Previously, Witnesses accepted only continuous-circuit autotransfusion, where blood never leaves the body’s connected tubing. Any form of stored autologous blood was not permitted. However, recent guidance from their Governing Body means that members may now opt for expanded use of autotransfusion, including emergency collection and brief storage while equipment and specialists are mobilized wherever they are needed. This change is especially meaningful during unexpected hemorrhage, when every milliliter counts and rapid preservation can shape the final outcome for the patient.
Over the last few decades, Jehovah Witness autotransfusion has been applied to surgical procedures where preservation of life was more important than long-term outcome. These experiences have led to new insights in procedures where autotransfusion may have normally been restricted such as oncology and obstetrics. As clinical teams have gained confidence and evidence, the use of autologous blood transfusion has expanded across a wider range of procedures. This progress signals that autotransfusion is becoming safer and more well-known among the general public.
The Update in Transfusion Guidance
According to the 2020 US Religion Census, about 3 million people in the US report to be Jehovah’s Witnesses. Jehovah’s Witnesses have a metaphysical belief in the sanctity of life, and that belief is physically correlated with an individual’s blood. For this reason, allogeneic blood transfusions are prohibited, which can create limitations in medical or surgical treatment.
However, in March 2026, the Governing Body of Jehovah’s Witnesses released an update permitting the use of autotransfusion, allowing each person to judge for themselves on the matter of storing and receiving back their own blood.
The update stated: “The Governing Body has decided to clarify its position on the use of a patient’s own blood in medical and surgical care. The clarification is this: Each must decide for himself how his own blood will be used in all medical and surgical care. This includes whether to allow his own blood to be removed, stored, and then given back to him.”
Allogeneic blood transfusions are still not allowed, but autologous blood transfusion is officially a viable option for Jehovah’s Witnesses who feel comfortable with its use.
Autotransfusion Is Becoming a Safe and Effective Option for More Patients
Autotransfusion is opening doors for care for Jehovah’s Witnesses and quickly becoming a safer and more effective method for procedures for all patients than allogeneic blood transfusions. Cell saver technology is efficient and displaces time-consuming processes involved in acquiring, matching, and transporting donated blood. Additionally, autologous blood is more oxygenated and only needs to be stored for short periods; donated blood can lose fluidity over time, and it has a shelf life of just over 40 days before it can no longer be used.
Autologous blood does not trigger the same immune response as donated blood, which can mean shorter recovery times and fewer complications. Research shows that it reduces the need for donated blood and does not contribute to adverse outcomes. Autotransfusion is beneficial for patients because it’s readily available and can speed healing time, and it’s more cost-effective for hospitals because it decreases the numerous expenses involved in obtaining, storing and using donated blood. Additionally, hospitals must accept the cost of unavoidable waste created by maintaining an inventory for an unpredictable level of demand. In contrast, autotransfusion uses the patient’s own blood in real time, returning the available volume of red cells lost.
Autotransfusion Services from SpecialtyCare
If you’d like to improve your use of cell saver technology to serve more patients, reduce length of stay, and retain revenue currently being spent on donated blood, contact SpecialtyCare today. We follow all AABB standards, and our technicians are highly experienced and collaborative, blending into your teams and supporting your workflow. From the OR to the ER, whether in hospital settings or ASCs, we can help you provide high quality autotransfusion services for greater cost savings and improved outcomes. Get in touch with us today to learn more!
